Opus Genetics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Opus Genetics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Opus Genetics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $20.1M, a 13.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $20.1M +$2.37M +13.3% Dec 31, 2023 10-K 2024-03-08
Q4 2022 $17.8M -$3.89M -18% Dec 31, 2022 10-K 2024-03-08
Q4 2021 $21.7M +$17M +366% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $4.65M +$2.79M +150% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $46.1M +$1.05M +2.32% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $45.6M +$1.16M +2.61% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $44.9M +$917K +2.08% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.86M -$41.1M -95.7% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $45.1M +$3.4M +8.17% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $44.5M +$3.99M +9.87% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $44M +$4.88M +12.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $43M +$5.36M +14.2% Dec 31, 2018 10-K 2020-02-21
Q3 2018 $41.7M -$8.88M -17.6% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $40.5M -$8.71M -17.7% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $39.2M -$8.38M -17.6% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $37.6M -$8.41M -18.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $50.5M +$5.12M +11.3% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $49.2M +$5.19M +11.8% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 $47.5M +$4.79M +11.2% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $46M +$5.18M +12.7% Dec 31, 2016 10-K 2018-03-09
Q3 2016 $45.4M +$5.57M +14% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $44M +$6.01M +15.8% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $42.7M +$6.6M +18.2% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $40.9M +$6.4M +18.6% Dec 31, 2015 10-K 2017-02-24
Q3 2015 $39.9M +$6.97M +21.2% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $38M +$6.41M +20.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $36.1M +$5.8M +19.1% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $34.5M +$5.09M +17.3% Dec 31, 2014 10-K 2016-03-14
Q3 2014 $32.9M +$4.45M +15.6% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $31.6M +$3.83M +13.8% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $30.3M +$3.33M +12.3% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $29.4M +$3.09M +11.7% Dec 31, 2013 10-K 2015-03-16
Q3 2013 $28.4M +$2.56M +9.9% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $27.7M +$52.9M Jun 30, 2013 10-Q 2013-08-12
Q1 2013 $27M Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $26.3M +$2.58M +10.9% Dec 31, 2012 10-K 2014-03-21
Q3 2012 $25.9M Sep 30, 2012 10-Q 2012-11-08
Q2 2012 -$25.2M Jun 30, 2012 10-Q 2012-08-08
Q4 2011 $23.7M Dec 31, 2011 10-K 2013-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.